Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.
Sonawane K, Castellano T, Washington C, Ting J, Surinach A, Kirshner C, Chhatwal J, Ayer T, Moore K. Sonawane K, et al. Among authors: castellano t. Gynecol Oncol Rep. 2022 Dec 13;44:101121. doi: 10.1016/j.gore.2022.101121. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36589508 Free PMC article.
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
LaFargue CJ, Handley KF, Fleming ND, Nick AM, Chelariu-Raicu A, Fellman B, Castellano T, Ogasawara A, Hom-Tedla M, Blake EA, da Costa AABA, Crim AK, Rauh-Hain A, Westin SN, Coleman RL, Matsuo K, Baiocchi G, Hasegawa K, Moore K, Sood AK. LaFargue CJ, et al. Among authors: castellano t. Gynecol Oncol. 2022 Apr;165(1):82-89. doi: 10.1016/j.ygyno.2022.02.006. Epub 2022 Feb 23. Gynecol Oncol. 2022. PMID: 35216808 Free PMC article.
Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.
Sonawane K, Castellano T, Washington C, Ting J, Surinach A, Kirshner C, Chhatwal J, Ayer T, Moore K. Sonawane K, et al. Among authors: castellano t. Gynecol Oncol Rep. 2022 Nov 5;44(Suppl 1):101101. doi: 10.1016/j.gore.2022.101101. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36506039 Free PMC article.
34 results